| # | Drug | Count |
|---|---|---|
| 0 | ERGOCALCIFEROL | 42 |
| 1 | GABAPENTIN | 38 |
| 2 | ACETAMINOPHEN | 32 |
| 3 | PREDNISONE | 32 |
| 4 | CETIRIZINE HYDROCHLORIDE | 29 |
| 5 | DUPILUMAB | 24 |
| 6 | OMEPRAZOLE MAGNESIUM | 24 |
| 7 | IBUPROFEN | 23 |
| 8 | NAPROXEN SODIUM | 22 |
| 9 | OMEPRAZOLE | 22 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DARIDOREXANT | 10 | 0.0036 |
| 1 | SOLRIAMFETOL | 10 | 0.0026 |
| 2 | DEXTROMETHORPHAN HYDROBROMIDE, BUPROPION HYDROCHLORIDE | 6 | 0.0017 |
| 3 | INFLIXIMAB-DYYB | 5 | 0.0015 |
| 4 | ERGOCALCIFEROL | 42 | 0.0014 |
| 5 | CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES | 11 | 0.0012 |
| 6 | UBROGEPANT | 7 | 0.0011 |
| 7 | ASFOTASE ALFA | 10 | 0.0010 |
| 8 | BISACODYL SUPPOSITORIES | 10 | 0.0008 |
| 9 | BISCODYL | 10 | 0.0008 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 71 |
| 1 | Corticosteroid [EPC] | 56 |
| 2 | Provitamin D2 Compound [EPC] | 42 |
| 3 | Benzodiazepine [EPC] | 41 |
| 4 | Proton Pump Inhibitor [EPC] | 33 |
| 5 | Vitamin C [EPC] | 32 |
| 6 | Tumor Necrosis Factor Blocker [EPC] | 26 |
| 7 | Interleukin-4 Receptor alpha Antagonist [EPC] | 24 |
| 8 | Atypical Antipsychotic [EPC] | 22 |
| 9 | Expectorant [EPC] | 21 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Oxaborole Antifungal [EPC] | 1 | 0.0143 |
| 1 | Dopamine and Norepinephrine Reuptake Inhibitor [EPC] | 10 | 0.0026 |
| 2 | Calcitonin Gene-related Peptide Receptor Antagonist [EPC] | 11 | 0.0016 |
| 3 | Type I Interferon Receptor Antagonist [EPC] | 3 | 0.0016 |
| 4 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 5 | Provitamin D2 Compound [EPC] | 42 | 0.0014 |
| 6 | Adrenocorticotropic Hormone [EPC] | 1 | 0.0011 |
| 7 | Endoglycosidase [EPC] | 2 | 0.0011 |
| 8 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 10 | 0.0010 |
| 9 | Insulin-like Growth Factor-1 Receptor Inhibitor [EPC] | 5 | 0.0008 |